专利的不完美：呼吁重新思考知识产权在全球健康中的作用

To expand access to medicines, two advocates call for rethinking intellectual property’s role in global health Elie Dolgin PHARMA MONOPOLY | When COVID-19 emerged, the race to develop vaccines was accompanied by an unusual degree of consensus about how such medicines should be shared. In those first uncer- tain months of 2020, governments, global health agencies, and philanthropic groups all spoke of fairness, warning that a scramble for limited doses could deepen existing divides between rich and poor countries. The hope was that, unlike earlier public health crises, scientific triumph would be matched by an equitable global rollout. Yet when vaccines began to arrive, the logic of national interest quickly reasserted itself. …